HDL Therapeutics CEO and key executive team

HDL Therapeutics's Chairman of the Board, CEO is Michael M. Matin. HDL Therapeutics's key executives include Michael M. Matin and 5 others.
Michael M. Matin

Michael M. Matin

Chairman of the Board, CEO
D. J. Brignola

D. J. Brignola

Chief Financial Officer
H. Bryan Brewer

H. Bryan Brewer

Chief Scientific Officer
Nicholas G. Rothwell

Nicholas G. Rothwell

VP, Global Supply
Timothy J. Perlman

Timothy J. Perlman

VP, Systems Development & Clinical Operations
Lori A. Carr

Lori A. Carr

VP, Quality Management & Regulatory Affairs
Last updated: